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Abstract
Background: Surveillance for drug-resistant Plasmodium falciparum should be a component of
malaria control programmes. Real-time PCR methods for the detection of parasite single-
nucleotide polymorphisms (SNPs) and gene amplification could be useful survellance tools.
Methods:  A real-time PCR assay has been developed that identifies single nucleotide
polymorphisms (SNPs) at amino acids 86, 184, 1034 and 1042 in the P. falciparum multi-drug
resistant (pfmdr 1) gene that may be associated with anti-malarial drug resistance.
Results: This assay has a sensitivity and specificity of 94% and 100% when compared to traditional
PCR methods for genotyping. Only 54 of 68 (79%) paired pre- and post-culture DNA samples were
concordant at all four loci.
Conclusion:  Real-time PCR is a sensitive and specific method to detect SNP's in pfmdr 1.
Genotypes of parasites after in vitro culture may not reflect that seen in vivo.
Background
The increasing prevalence of multi-drug resistant parasites
threatens to impede efforts to control malaria world-wide
[1]. Current in vitro and in vivo methods to monitor the
emergence of drug resistance are difficult, costly and
labor-intensive. Molecular methods could prove to be
useful alternatives [2].
For  Plasmodium falciparum, the pfmdr 1 gene product,
PGH1, is thought to play an integral role in the mecha-
nism behind parasite resistance to multiple malarial drugs
[3]. Both increased gene copy number and single-nucle-
otide polymorphisms (SNP's) have been associated in
epidemiological studies with changes in sensitivity to
chloroquine and mefloquine (reviewed in [1,4,5]). In two
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studies from South-east Asia, both increased pfmdr 1 gene
copy number and SNPs have been associated with in vitro
resistance to mefloquine [6,7].
In this manuscript, a real-time PCR assay has been devel-
oped for the detection of pfmdr 1 SNPs. This assay was
developed to be used in conjunction with a previously
developed assay for pfmdr 1 gene copy number [6] to
assess molecular markers as predictors of mefloquine fail-
ure in a clinical study that took place in Sangkhlaburi,
Thailand, in 2001–2. The results of the clinical study will
be described in a subsequent publication.
Numerous studies have shown discrepancies between in
vitro and in vivo tests for antimalarial drug resistance [8-
11]. In order to understand why, pfmdr 1 genotypes were
determined directly from patient blood and from cultures
derived from those patients and compared.
Methods
Patient samples
Subject recruitment. This study received ethical approval
from the University of North Carolina IRB and the Thai
Ministry of Public Health. Patients presenting with slide-
confirmed falciparum malaria to the free Ministry of Pub-
lic Health malaria clinic or the Kwai River Christian Hos-
pital clinic in Sangklaburi, Thailand from during July
2001 – August 2002 were enrolled. Patients with vivax
infections, history of anti-malarial drug use within the
past two weeks, bleeding tendency (by self-reported his-
tory or based on medical records), or severe/complicated
malaria requiring prompt medical management for life
support were excluded. In total, 74 patients consented.
Blood samples were taken, aliquoted, stored in liquid
nitrogen, and transported to the Armed Forces Research
Institute for the Medical Sciences (AFRIMS) in Bangkok.
At AFRIMS, aliquots were thawed for in vitro culture. 59 of
the 74 patient blood samples were successfully cultured as
previously described [6,12]. Parasites were cultured for
between 2 and 188 days (mean = 38.5; median = 23).
DNA was extracted from patient blood ("pre-culture")
and cultured parasites ("post-culture") using the QiaAmp
DNA Blood Minikit Blood and Body Fluid Spin Protocol
(Qiagen, Valencia, CA) and then shipped on dry ice to the
University of North Carolina.
Standard PCR
DNA was PCR-amplified using a MJ Thermocycler (MJ
Research, Waltham, MA) as previously described [6]. DNA
sequencing was performed at the University of North
Carolina Sequencing Core facility using a 3100 Genetic
Analyser (Applied Biosystems, Foster City, CA). The
sequencing reaction was done using the ABI PRISM™
BigDye™ Terminator Cycle Sequencing Ready Reaction Kit
with AmpliTaq®  DNA Polymerase, FS (Applied
Biosystems).
Real-time PCR
For real-time PCR, pre-culture DNA and post-culture DNA
were genotyped using an Applied Biosystems Prism 7000
Sequence Detection System (Applied Biosystems). This
assay uses sequence-specific fluorescently-labelled
"MGB™ " probes to distinguish SNPs [13-15]. Primers and
probes (Table 1) were designed using Primer Express Soft-
ware, Version 2.0 (Applied Biosystems). Primers were
obtained from Qiagen. Fluorescent MGB™ probes were
Table 1: Primers and probes used in real-time PCR assay
Pfmdr1 Oligonucleotide (5'--> 3') Tm**
86 F TGTATGTGCTGTATTATCAGGAGGAAC 63.1
R AATTGTACTAAACCTATAGATACTAATGATAATATTATAGG 61.7
Asn (wt*) probe 6FAM-ACCTAAATTCATGTTCTTT-MGB-NFQ 66.5
Tyr (mut**) probe VIC-ACCTAAATACATGTTCTTT-MGB-NFQ 65.8
184 F AAGATGGACAATTTCATGATAATAATCCT 59
R AATACATAAAGTCAAACGTGCATTTTTTA 57.6
Tyr (wt) probe 6FAM-CTTTTTAGGTTTATATATTTGGT-MGB-NFQ 65.2
Phe (mut) probe VIC-CTTTTTAGGTTTATTTATTTGGT-MGB-NFQ 65.9
1034 F AAAAAGAAGAATTATTGTAAATGCAGCTT 57.6
R GGATCCAAACCAATAGGCAAAA 58.9
Ser (wt) probe 6FAM-ATTCAGTCAAAGCGCT-MGB-NFQ 65.8
Cys (mut) probe VIC-ATTCTGTCAAAGCGCT-MGB-NFQ 66.7
1042 F AAAAAGAAGAATTATTGTAAATGCAGCTT 57.6
R TTTCCAGCATAACTACCAGTAAATATAAAAG 60.7
Asn (wt) probe 6FAM-CAATTATTTATTAATAGTTTTGC-MGB-NFQ 65.3
Asp (mut) probe VIC-AATTATTTATTGATAGTTTTGC-MGB-NFQ 64.8
* Wild type (Asn86, Tyr1 84, Serl034 or Asnl042) sequence ** Mutant (Tyr86, Phe184, Cysl034 or Aspl042) sequence *** Melting temperature 
estimated by Primer press v2.0 For probes, the reporter dye is covalently attached at the 5'end (6FAM or VIC) with a minor groove binder (MGB) 
and non-fluorescent quencher (NFQ) covalently attached at the 3' end.Malaria Journal 2004, 3 http://www.malariajournal.com/content/3/1/9
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produced by Applied Biosystems and labelled with
reporter dyes, 6FAM or VIC, at their 5' ends and non-fluo-
rescent quencher molecules at their 3' ends. Primer and
probe concentrations were optimized according to the
TaqMan Universal PCR Master Mix technical bulletin
(Applied Biosystems) using DNA obtained from P. falci-
parum strain 3D7 or from patient specimens. 300 nM of
both forward and reverse primers were found to be opti-
mal for all SNPs. Optimal probe concentration was deter-
mined to be 250 nM for all MGB probes used in this
study. Using 10-fold serial dilutions of 3D7 genomic P.
falciparum DNA, as few as 8 copies (0.001 ng) of genomic
P. falciparum DNA could be detected.
Each real-time PCR amplification reaction contained both
the wild type probe labelled with FAM, and the mutant
probe labelled with VIC. Presence of either SNP could be
imputed from the relative increase of fluorescence of the
two fluorophores (Fig. 1). All reactions were done in
duplicate.
Results
Parasite culture
Of the 74 patients enrolled, parasites were successfully
cultured from 59. Following treatment, 20 of the 74
admission patients recrudesced. Parasites were success-
fully cultured from 13 of these 20 recrudescent patients.
Sensitivity and Ssecificity of Real-Time PCR
The sensitivity and specificity of SNP detection using real-
time PCR were measured in 22 post-culture DNA samples
using DNA sequencing as the gold standard (Table 2).
Fluorescent intensity (Rn) of the FAM reporter dye (blue line) compared to VIC reporter dye (green line) as PCR amplification  cycles proceed (x axes) Figure 1
Fluorescent intensity (Rn) of the FAM reporter dye (blue line) compared to VIC reporter dye (green line) as PCR amplification 
cycles proceed (x axes). Fluorescent intensity is measured as Rn (y-axes), the absolute fluorescence of the reporter dye divided 
by that of the passive reference dye, Rox. An increase in FAM indicates a wild type population [86(e), 184(f), 1034(g), 1042(h)] 
while an increase in VIC indicates a mutant population [86(a), 184(b), 1034(c), 1042(d)]. Polyclonal infections may be identified 
by an increase in fluorescent intensity of both reporter dyes (not shown). Mutant 1034 DNA (c) was obtained from a previous 
study [6] because none of the samples in this study contained that mutation.
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Nineteen cultures were derived from blood of patients
upon admission to the study. The other three cultures
were obtained from who failed treatment. Two samples
contained mixtures of SNPs at single positions based on
DNA sequencing. Of the 20 monoclonal samples, 19 were
concordant for all pfmdr 1 SNPs when analysed using both
methods. The discordant sample was not an artefact since
both the real-time PCR and sequencing reactions gave
identical results when repeated. The discordant sample
contained a single discrepancy at position 184 (phenyla-
lanine by sequencing and tyrosine by real-time PCR).
Thus, the sensitivity of real-time PCR method to detect
Tyr86 or Asp1042 SNPs was 100% and the sensitivity to
detect Phel84 was 92%; there were no Cysl034 mutations
detected. Real-time PCR was 100% specific for each muta-
tion. The sensitivity and specificity of the assay to detect
all four SNPs were 94% and 100%, respectively.
Two of the 22 samples were found to be mixed infections
when sequenced. One sample contained a mixture of
Tyrl84 and Phel84. The other sample contained a mixture
of Asn86 and His86. The real-time PCR method accurately
identified the Tyrl84/Phel84 mixed population. However,
because the probes were designed to detect only Asn86 or
Tyr86, His86 was not detected by real-time PCR.
Comparison of SNPs pre- and post-culture
In order to determine how the process of culturing para-
sites  in vitro alters genotype, a comparison was made
between the pfmdr 1 genotypes of DNA extracted from
pre-and post-culture parasites as measured by real-time
PCR. Of the paired pre- and post-culture specimens, both
members of 68 pairs were successfully amplified by real-
time PCR. Fifty-eight of these pairs were obtained from
admission patient blood while 10 pairs were derived from
recrudescent patients.
Fifty-eight of the pre-culture genotypes were monoclonal,
nine pre-culture samples had mixtures of alleles at single
positions, and one had mixed SNPs at two positions (184
and 1042). Table 3 shows the number of isolates with spe-
cific combinations of pfmdr 1 genotypes pre- and post-cul-
ture at each specific locus. Isolates with identical genotype
at each locus before and after culture are enumerated in
Table 2: Prevalence in monoclonal culture samples (n = 20) of mutations detected by traditional PCR and sequencing (gold standard) 
and real-time PCR, and sensitivity and specificity of realtime PCR assay.
Prevalence Real-time PCR
PCR Real-time PCR Sensitivity Specificity
Tyr86 5% 5% 1/1 (100%) 19/19 (100%)
Phel84 65% 12/13 (92%) 7/7 (100%)
Cysl034 0% 0% 0/0 (--) 20/20 (100%)
Asp 1042 10% 10% 2/2 (100%) 18/18 (100%)
All mutations correct -- -- 15/16 (94%) 64/64 (100%)
Table 3: Genotype results of DNA from pre-culture and post-culture DNA by real-time PCR
Pre-culture genotype results Post-culture genotype results
Codon 86 184 1042
Amino Acid Asn Tyr His Tyr Tyr & Phe Phe Asn Asn & Asp Asp
86 Asn 64 -- 1
Tyr 1 2
His -- --
184 Tyr 27 1 2
Tyr & Phe 2 4 3
Phe 3 -- 27
1042 Asn 60 -- 3
Asn & Asp 1 1
Asp -- -- 3
Data for codon 1034 was omitted because no mutant or polyclonal infections were detected in the 68 paired samples.Malaria Journal 2004, 3 http://www.malariajournal.com/content/3/1/9
Page 5 of 6
(page number not for citation purposes)
the shaded diagonal. Overall, fifty-four of 68 (79%) pre-
culture DNA samples were completely concordant with
post-culture DNA at all four polymorphic sites examined.
While there was a wide variation in the length of time par-
asites were cultured before DNA was extracted, there was
no correlation between genotype discordances and length
of time in culture (data not shown). Five of the 14 dis-
cordant isolates exhibited single differences at position
184, and two were different at position 1042. Seven dis-
crepant samples contained mixtures of alleles at one or
more sites before and/or after culture. Six samples showed
a mixture of alleles pre-culture and single alleles post-cul-
ture. This type of selection occurred at amino acid 184 for
four isolates, and 1042 for two isolates. Two of these six
also had changes at a second position, amino acid 86.
Finally, one of the seven samples was monoclonal at ami-
noacid 184 pre-culture but polyclonal post-culture (and
also exhibited a change from Asn to Asp at 1042).
Novel His86 mutation identified
In one DNA culture sample neither wild type nor mutant
probes revealed amplification during real-time PCR. This
post-culture sample was amplified by standard PCR meth-
ods and sequenced to genotype the position 86 region.
Sequencing this sample revealed a His86.
Discussion
In this paper, a real-time PCR method is described which
accurately ascertains parasite pfmdr 1 genotype. This
method has high sensitivity (94%) and specificity (100%)
for detecting four pfmdr 1 SNPs associated with drug
resistance. There was a 21% discordance in the real-time
PCR genotype results between DNA samples obtained
directly from patient blood and DNA samples obtained
from subsequent in vitro cultures.
Real-time PCR offers several advantages over standard
PCR methods for genotyping DNA. First, because of the
small volume the material, costs for real-time PCR are
much lower than for standard PCR and are as little as
$0.40 per reaction. Second, using real-time PCR, a single
technician can perform and analyse hundreds of reactions
per day, thus reducing the labor cost as well. Third, this
method reduces the opportunity for post-PCR contamina-
tion. Once the sample is prepared with the reagents,
amplification and analysis are completed in a closed-tube
system. Finally, real-time PCR analysis of genotype is eas-
ier and requires less scientific expertise for analysis. Thus,
the initial cost of a real-time PCR instrument (~$40,000)
would be offset by savings in labor, quality assurance, and
materials in labs analysing large numbers of samples.
In this paper, a novel His86 mutation was identified in
two samples. To our knowledge, this mutation has never
been identified before and may or may not be associated
with drug resistance. Further studies on this mutation are
needed.
A previous study utilized a novel real-time PCR technol-
ogy to identify pfmdr 1 SNPs in parasite DNA extracted
from clinical blood samples [16]. Although the chemistry
of the assay differed from the technique described here,
both studies yielded similar results and concluded that
real-time PCR may accurately detect Asn86 → Tyr86, Tyr184
→ Phe184, Ser1034 → Cys1034 and Asn1042 → Asp1042 in
pfmdr 1. In addition, de Monbrison, et al., used this
method to genotype Asp1246 → Tyr1246. SNPs at 1246 were
not studied here because they have not been found in
South-east Asia [6,7].
Twenty-one percent of samples manifested differences in
pfmdr 1 genotype pre- and post-culture. Since most
patients are probably infected with a mixture of strains,
the genotypes observed post-culture reflects the results of
the selection of a subset of strains by in vitro culture con-
ditions. This could manifest itself as loss of strains
observed pre-culture or the appearance of strains not
observed pre-culture because they were present at levels
below detection limits. A much greater change in geno-
type (74.5%) was observed in a previous study looking at
variations in the polymorphic regions of MSP1 and MSP2
(merozoite surface protein 1 and 2) as well as GLURP
(glutamate-rich protein) [17], perhaps because these
genes are more variable.
In addition to SNP detection, our group has previously
described a real-time PCR method to measure pfmdr 1
gene amplification [6]. Thus it is now possible to assess
both pfmdr 1 gene copy number and SNPs using real-time
PCR making it possible to carry out a complete assessment
of pfmdr 1 genetics in large cohorts.
Conclusions
Real-time PCR is a sensitive and specific method to detect
pfmdr 1 mutations and gene amplification. Because it is
inexpensive and amenable to high-throughput, it could
be a useful public health tool.
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